Genetic polymorphisms of macrophage-mediators in Guillain–Barré syndrome
Authors:
- Karin GeleijnsKGKarin Geleijns
- Marieke EmontsMEMarieke Emonts
- Jon D. LamanJLJon D. Laman
- Wouter van RijsWRWouter van Rijs
- Pieter A. van DoornPDPieter A. van Doorn
- Peter W.M. HermansPHPeter W.M. Hermans
- Bart C. JacobsBJBart C. Jacobs
- 1 October 2007
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 190 (1-2) , 127-130
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mannose-Binding Lectin Contributes to the Severity of Guillain-Barré SyndromeThe Journal of Immunology, 2006
- Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trialJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Genetic association studiesThe Lancet, 2005
- Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patientsJournal of Neuroimmunology, 2004
- Interleukin-10 promoter polymorphisms in patients with Guillain–Barré syndromeJournal of Neuroimmunology, 2003
- The role of macrophages in immune-mediated damage to the peripheral nervous systemProgress in Neurobiology, 2001
- Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndromeNeurology, 1999
- Genetic contribution of the tumor necrosis factor region in guillain‐barré syndromeAnnals of Neurology, 1998
- Circulating tumor necrosis factor (TNF)-α and soluble TNF-α receptors in patients with Guillain-Barré syndrome11Study supported by a grant from Délégation à la Recherche clinique (AP/HP).Journal of Neuroimmunology, 1996
- Guillain-Barré syndrome in northern China: The spectrum of neuropathological changes in clinically defined casesBrain, 1995